An evaluation determined that productivity costs and the value of quality of life lost were very important to the impact to those with the wet form of this condition, as well as GA.
A study involving over 18,000 patients with the condition found that by 36 months, 19% progressed to neovascular AMD, which doubled the risk of exudative conversion in the fellow eye.